Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies-Reference-Cited by-同舟云学术

Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies

Published:2022-12-21 Issue: Volume: Page:1-7
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Uludag Gunay¹,Karaca Irmak¹^ORCID,Akhavanrezayat Amir¹,Yasar Cigdem¹,Matsumiya Wataru¹²,Pham Brandon Huy¹³^ORCID,Halim Muhammad Sohail¹⁴,Trong Tuong than Ngoc¹,Sepah Yasir J.¹,Do Diana V.¹,Nguyen Quan Dong¹

Affiliation:

1. Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California, USA

2. Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan

3. Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Health System, Miami, Florida, USA

4. Ocular Imaging Research and Reading Center, Sunnyvale, California, USA

Funder

receive

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2022.2126374

Reference34 articles.

1. Utilisation of composite endpoint outcome to assess efficacy of tocilizumab for non-infectious uveitis in the STOP-Uveitis Study

2. Intraocular therapy in noninfectious uveitis

3. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop

4. Retinal imaging in uveitis

5. Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating tocilizumab safety and immunomodulatory effects under ocular HTLV-1 infection in vitro;International Immunopharmacology;2024-08

2. Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis;Ocular Immunology and Inflammation;2024-05-23

3. Options for systemic therapy of uveitis including alternative therapies;Expert Review of Ophthalmology;2024-03-05

4. Nicht-infektiöse anteriore Uveitis;Die Ophthalmologie;2024-03-04

5. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis;Expert Opinion on Investigational Drugs;2024-02